SAN

83.34

+0.43%↑

MRK1

111.25

-0.22%↓

SHL.DE

47.42

+1.22%↑

ARGX

464.9

+0.5%↑

FRE

42.32

+0.93%↑

SAN

83.34

+0.43%↑

MRK1

111.25

-0.22%↓

SHL.DE

47.42

+1.22%↑

ARGX

464.9

+0.5%↑

FRE

42.32

+0.93%↑

SAN

83.34

+0.43%↑

MRK1

111.25

-0.22%↓

SHL.DE

47.42

+1.22%↑

ARGX

464.9

+0.5%↑

FRE

42.32

+0.93%↑

SAN

83.34

+0.43%↑

MRK1

111.25

-0.22%↓

SHL.DE

47.42

+1.22%↑

ARGX

464.9

+0.5%↑

FRE

42.32

+0.93%↑

SAN

83.34

+0.43%↑

MRK1

111.25

-0.22%↓

SHL.DE

47.42

+1.22%↑

ARGX

464.9

+0.5%↑

FRE

42.32

+0.93%↑

Search

Vetoquinol SA

Gesloten

SectorGezondheidszorg

76.8 2.4

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

71

Max

76.9

Belangrijke statistieken

By Trading Economics

Inkomsten

35M

Verkoop

275M

K/W

Sectorgemiddelde

15.06

40.527

Dividendrendement

1.2

Winstmarge

12.694

Werknemers

2,437

EBITDA

60M

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

1.20%

2.40%

Volgende Winsten

11 sep 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

904M

Vorige openingsprijs

74.4

Vorige sluitingsprijs

76.8

Nieuwssentiment

By Acuity

50%

50%

162 / 376 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Bearish Evidence

Vetoquinol SA Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

8 jul 2025, 19:37 UTC

Belangrijke Marktbewegers
Acquisities, Fusies, Overnames

M3-Brigade Shares Fall on Merger With ReserveOne

8 jul 2025, 23:45 UTC

Marktinformatie

Gold Edges Lower, Weighed by Higher Treasury Yields -- Market Talk

8 jul 2025, 23:42 UTC

Marktinformatie

Nikkei May Rise as Yen Weakens -- Market Talk

8 jul 2025, 23:27 UTC

Marktinformatie

Australian REITs Yet to Offer Enough Appeal -- Market Talk

8 jul 2025, 23:27 UTC

Marktinformatie

Global Equities Roundup: Market Talk

8 jul 2025, 23:21 UTC

Marktinformatie

Summerset Bull Lauds Strong 2Q Sales Volumes -- Market Talk

8 jul 2025, 23:21 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

8 jul 2025, 22:29 UTC

Acquisities, Fusies, Overnames

Capricorn to Pay A$1.5 Million in Cash and Shares

8 jul 2025, 22:28 UTC

Acquisities, Fusies, Overnames

Capricorn Metals Enters Binding Agreement to Buy Claw Gold Project

8 jul 2025, 21:58 UTC

Marktinformatie

Kura Sushi Closely Watching U.S. Tariff Negotiations on Asian Goods -- Market Talk

8 jul 2025, 20:50 UTC

Marktinformatie

Financial Services Roundup: Market Talk

8 jul 2025, 20:50 UTC

Marktinformatie

Tech, Media & Telecom Roundup: Market Talk

8 jul 2025, 20:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

8 jul 2025, 20:15 UTC

Marktinformatie

Global Commodities Roundup: Market Talk

8 jul 2025, 19:53 UTC

Marktinformatie

Copper Posts Biggest One-Day Gain Ever to Hit Record on Tariff Chatter -- Market Talk

8 jul 2025, 19:53 UTC

Marktinformatie

Market Talk Roundup: Latest on U.S. Politics

8 jul 2025, 19:45 UTC

Marktinformatie

Canada Unlikely to Succeed in Bid for Tariff-Free Trade With U.S. -- Market Talk

8 jul 2025, 19:29 UTC

Marktinformatie

U.S. Consumer-Credit Growth Slowed in May -- Market Talk

8 jul 2025, 19:20 UTC

Marktinformatie

U.S. Natural Gas Futures Settle Lower -- Market Talk

8 jul 2025, 19:11 UTC

Marktinformatie

Bank of Canada's Rate Cuts Deliver Muted Relief Along the Curve -- Market Talk

8 jul 2025, 19:01 UTC

Marktinformatie

Oil Futures Gain With Support From Products -- Market Talk

8 jul 2025, 18:49 UTC

Winsten

Hershey Names New CEO, Continuing Leadership Shuffle. The Stock Falls. -- Barrons.com

8 jul 2025, 18:41 UTC

Marktinformatie

Mexico's Inflation Seen Mixed in June -- Market Talk

8 jul 2025, 18:38 UTC

Marktinformatie

Gold Falls as Markets Digest Details of Trump Tariffs -- Market Talk

8 jul 2025, 18:23 UTC

Marktinformatie

Analysts Anticipate Lower Ethanol Inventories -- Market Talk

8 jul 2025, 18:10 UTC

Marktinformatie

Market Talk Roundup: Latest on U.S. Politics

8 jul 2025, 18:10 UTC

Marktinformatie

Freeport-McMoRan Jumps on Trump Tariff Plan for Copper Imports -- Market Talk

8 jul 2025, 17:24 UTC

Marktinformatie

Election, Dollar Seen as Potential Headwinds for Ibovespa -- Market Talk

8 jul 2025, 17:06 UTC

Marktinformatie

KeyCorp and Regional Banks Set for a Catchup -- Market Talk

8 jul 2025, 16:20 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

Peer Vergelijking

Prijswijziging

Vetoquinol SA Prognose

Beoordelingsconsensus

By TipRanks

0 ratings

0

Buy

0

Hold

0

Sell

Technische score

By Trading Central

72.6 / 75.1Steun & Weerstand

Korte Termijn

Bearish Evidence

Gemiddeld Termijn

Bearish Evidence

Lange Termijn

Bearish Evidence

Sentiment

By Acuity

162 / 376 Rangschikking in Gezondheidszorg

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Vetoquinol SA

Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, sheep, pigs, poultry, dogs, cats, and horses. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.